We are live on ! Find out more
BSTC

BioSpecifics Technologies Corp.
BSTC

Delisted

BSTC was delisted on the 1st of December, 2020.

Back to rankings

116 hedge funds and large institutions have $294M invested in BioSpecifics Technologies Corp. in 2020 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 44 increasing their positions, 38 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

31% more first-time investments, than exits

New positions opened: 17 | Existing positions closed: 13

16% more repeat investments, than reductions

Existing positions increased: 44 | Existing positions reduced: 38

13% more capital invested

Capital invested by funds: $262M → $294M (+$32.8M)

3% more funds holding

Funds holding: 113 → 116 (+3)

Holders
116
Holders Change
+3
Holders Change %
+2.65%
% of All Funds
2.38%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
17
Increased
44
Reduced
38
Closed
13
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
PAIM
Punch & Associates Investment Management
Minnesota
+$2.89M
2
Russell Investments Group
Russell Investments Group
United Kingdom
+$2.72M
3
KCM
Kennedy Capital Management
Missouri
+$2.69M
4
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$2.43M
5
WG
Winton Group
United Kingdom
+$1.92M

Top Sellers

Rank Fund Capital Flow
1
Goldman Sachs
Goldman Sachs
New York
-$5.88M
2
Allianz Asset Management
Allianz Asset Management
Germany
-$1.26M
3
AQR Capital Management
AQR Capital Management
Connecticut
-$1.2M
4
Millennium Management
Millennium Management
New York
-$755K
5
Wells Fargo
Wells Fargo
California
-$541K
Name Holding Trade Value Shares
Change 		Change in
Stake
EAM
26
Eagle Asset Management
Florida
$2.24M -$235K -4,067 -10%
CCM
27
Cadence Capital Management
Massachusetts
$2.16M -$507K -8,762 -20%
Citadel Advisors
28
Citadel Advisors
Florida
$2.15M +$296K +5,117 +17%
LSV Asset Management
29
LSV Asset Management
Illinois
$1.98M +$1.87M +32,361 New
Charles Schwab
30
Charles Schwab
California
$1.88M +$91.7K +1,586 +5%
Goldman Sachs
31
Goldman Sachs
New York
$1.79M -$5.88M -101,690 -78%
Man Group
32
Man Group
United Kingdom
$1.69M -$321K -5,550 -17%
Los Angeles Capital Management
33
Los Angeles Capital Management
California
$1.69M +$863K +14,916 +119%
PPA
34
Parametric Portfolio Associates
Washington
$1.63M +$350K +6,053 +30%
CAM
35
ClariVest Asset Management
California
$1.56M -$58.6K -1,013 -4%
Invesco
36
Invesco
Georgia
$1.41M +$5.9K +102 +0.4%
N
37
Nuveen
North Carolina
$1.41M -$183K -3,163 -12%
IP
38
Isthmus Partners
Wisconsin
$1.34M +$14.7K +254 +1%
SGI
39
Summit Global Investments
Utah
$1.3M +$278K +4,800 +29%
Ameriprise
40
Ameriprise
Minnesota
$1.28M +$185K +3,197 +18%
Bessemer Group
41
Bessemer Group
New Jersey
$1.27M +$972K +16,800 +430%
TCA
42
Transcend Capital Advisors
New Jersey
$1.27M – – –
WCM
43
Wisconsin Capital Management
Wisconsin
$1.23M +$1.16M +20,101 New
AWCI
44
Alpine Woods Capital Investors
New York
$1.01M +$116K +2,000 +14%
MPAM
45
Monarch Partners Asset Management
Massachusetts
$870K – – –
California Public Employees Retirement System
46
California Public Employees Retirement System
California
$849K +$16.9K +292 +2%
Swiss National Bank
47
Swiss National Bank
Switzerland
$803K +$150K +2,600 +25%
Cambridge Investment Research Advisors
48
Cambridge Investment Research Advisors
Iowa
$764K -$209K -3,617 -22%
MCM
49
Matarin Capital Management
New York
$644K +$608K +10,511 New
Two Sigma Advisers
50
Two Sigma Advisers
New York
$631K -$116K -2,000 -16%
1
2
3 4 5

BSTC Hedge Fund Activity: Q2 2020 in Review

116 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in BioSpecifics Technologies Corp. (BSTC) for Q2 2020, worth a combined $294M — up 13% from $262M a quarter earlier.

Buyers outnumbered sellers: 17 funds opened new BSTC positions and 13 closed out — a net gain of 4 holders — while 44 added to existing stakes and 38 trimmed.

The largest buyer was Punch & Associates Investment Management, opening a new position worth an estimated $2.89M. The largest seller was Goldman Sachs, cutting an estimated $5.88M.

  • 116 institutional investors held BioSpecifics Technologies Corp. (BSTC) as of Q2 2020, up from 113 in Q1 2020.
  • Funds reported $294M of BioSpecifics Technologies Corp. stock for Q2 2020, up 13% quarter-over-quarter.
  • 17 funds opened new BioSpecifics Technologies Corp. positions in Q2 2020 and 13 closed out, a net change of +4 holders.
  • The largest BioSpecifics Technologies Corp. buyer in Q2 2020 was Punch & Associates Investment Management, an estimated $2.89M added.
  • The largest BioSpecifics Technologies Corp. seller in Q2 2020 was Goldman Sachs, an estimated $5.88M sold.

Based on aggregated 13F filings for Q2 2020.